Secondary Hyperparathyroidism Treatment Market Trends and Regional Overview By Key Companies
Secondary hyperparathyroidism (SHPT) is a common and serious complication of chronic kidney disease (CKD), characterized by the excessive secretion of parathyroid hormone (PTH) due to chronic renal insufficiency. This condition leads to various skeletal and cardiovascular issues, significantly impacting patients' quality of life. The growing prevalence of CKD worldwide has driven significant...
0 Commentaires 0 Parts 2KB Vue 0 Aperçu
Commandité
Commandité
Commandité
google-site-verification: google037b30823fc02426.html